Alpha Tau Medical (DRTS) Operating Expenses (2021 - 2026)

Alpha Tau Medical (DRTS) has 6 years of Operating Expenses data on file, last reported at $13.1 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 47.72% year-over-year to $13.1 million; the trailing twelve-month figure through Mar 2026 stood at $44.7 million (up 28.86% YoY), and the FY2025 full-year result was -$5.0 million, down 3.02% from the prior year.
• Operating Expenses climbed to $13.1 million in Q1 2026, from $12.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $13.1 million in Q1 2026 to a low of $7.1 million in Q3 2022.
• A 5-year average of $8.9 million and a median of $8.5 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses soared 233.84% in 2022 and fell 7.31% in 2024, its largest moves.
• Tracing DRTS's Operating Expenses over 5 years: stood at $7.6 million in 2022, then gained by 25.08% to $9.5 million in 2023, then gained by 1.01% to $9.6 million in 2024, then gained by 26.73% to $12.1 million in 2025, then grew by 7.59% to $13.1 million in 2026.
• Business Quant data shows DRTS's Operating Expenses at $13.1 million in Q1 2026, $12.1 million in Q4 2025, and $10.2 million in Q3 2025.